Your browser doesn't support javascript.
loading
ARF1-related disorder: phenotypic and molecular spectrum.
de Sainte Agathe, Jean-Madeleine; Pode-Shakked, Ben; Naudion, Sophie; Michaud, Vincent; Arveiler, Benoit; Fergelot, Patricia; Delmas, Jean; Keren, Boris; Poirsier, Céline; Alkuraya, Fowzan S; Tabarki, Brahim; Bend, Eric; Davis, Kellie; Bebin, Martina; Thompson, Michelle L; Bryant, Emily M; Wagner, Matias; Hannibal, Iris; Lenberg, Jerica; Krenn, Martin; Wigby, Kristen M; Friedman, Jennifer R; Iascone, Maria; Cereda, Anna; Miao, Térence; LeGuern, Eric; Argilli, Emanuela; Sherr, Elliott; Caluseriu, Oana; Tidwell, Timothy; Bayrak-Toydemir, Pinar; Hagedorn, Caroline; Brugger, Melanie; Vill, Katharina; Morneau-Jacob, Francois-Dominique; Chung, Wendy; Weaver, Kathryn N; Owens, Joshua W; Husami, Ammar; Chaudhari, Bimal P; Stone, Brandon S; Burns, Katie; Li, Rachel; de Lange, Iris M; Biehler, Margaux; Ginglinger, Emmanuelle; Gérard, Bénédicte; Stottmann, Rolf W; Trimouille, Aurélien.
Afiliação
  • de Sainte Agathe JM; Department of Medical Genetics, Groupe Hospitalo-Universitaire Pitié-Salpêtrière, AP-HP.Sorbonne Université, Paris, France jean-madeleine.desainteagathe@aphp.fr.
  • Pode-Shakked B; Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Naudion S; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Michaud V; Service de Génétique Médicale, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
  • Arveiler B; Service de Génétique Médicale, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
  • Fergelot P; Maladies Rares : Génétique et Métabolisme (MRGM), U1211, INSERM, Bordeaux, France.
  • Delmas J; Service de Génétique Médicale, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
  • Keren B; Maladies Rares : Génétique et Métabolisme (MRGM), U1211, INSERM, Bordeaux, France.
  • Poirsier C; Service de Génétique Médicale, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
  • Alkuraya FS; Maladies Rares : Génétique et Métabolisme (MRGM), U1211, INSERM, Bordeaux, France.
  • Tabarki B; Pediatric and Prenatal Imaging Department, Centre Hospitalier Universitaire de Bordeaux Groupe hospitalier Pellegrin, Bordeaux, France.
  • Bend E; Department of Medical Genetics, Groupe Hospitalo-Universitaire Pitié-Salpêtrière, AP-HP.Sorbonne Université, Paris, France.
  • Davis K; Département de génétique médicale, CHU Reims, Reims, France.
  • Bebin M; Department of Translational Genomic, Center for Genomic Medicine, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
  • Thompson ML; Division of Pediatric Neurology, Department of Pediatrics, Prince Sultan Military and Medical City, Riyadh, Saudi Arabia.
  • Bryant EM; PreventionGenetics LLC, Marshfield, Wisconsin, USA.
  • Wagner M; Division of Medical Genetics, Royal University Hospital, Saskatoon, Saskatchewan, Canada.
  • Hannibal I; UAB Epilepsy Center, The University of Alabama at Birmingham Hospital, Birmingham, Alabama, USA.
  • Lenberg J; Greg Cooper's Laboratory, HudsonAlpha Institute for Biotechnology, Huntsville, Alabama, USA.
  • Krenn M; Gillette Children's Specialty Healthcare, Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
  • Wigby KM; Institute of Human Genetics, Technische Universitat Munchen, Munchen, Germany.
  • Friedman JR; Institute of Neurogenomics, Helmholtz Zentrum Munchen Deutsches Forschungszentrum fur Umwelt und Gesundheit, Neuherberg, Germany.
  • Iascone M; Department of Pediatrics, University Hospital Munich, Munchen, Germany.
  • Cereda A; Rady Children's Institute for Genomic Medicine, San Diego, California, USA.
  • Miao T; Department of Neurology, Medizinische Universitat Wien, Wien, Austria.
  • LeGuern E; Rady Children's Hospital-San Diego, University of California, San Diego, California, USA.
  • Argilli E; Department of Neuroscience, Rady Children's Institute for Genomic Medicine, San Diego, California, USA.
  • Sherr E; Division of Neurology, Rady Children's Hospital San Diego, San Diego, California, USA.
  • Caluseriu O; Laboratorio di Genetica Medica, ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Tidwell T; Pediatric Department, ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Bayrak-Toydemir P; Department of Medical Genetics, Groupe Hospitalo-Universitaire Pitié-Salpêtrière, AP-HP.Sorbonne Université, Paris, France.
  • Hagedorn C; École d'ingénieurs biotechnologies Paris - SupBiotech, Sup'Biotech, Paris, France.
  • Brugger M; Department of Medical Genetics, Groupe Hospitalo-Universitaire Pitié-Salpêtrière, AP-HP.Sorbonne Université, Paris, France.
  • Vill K; ICM, INSERM, Paris, France.
  • Morneau-Jacob FD; Department of Neurology, University of California San Francisco Division of Hospital Medicine, San Francisco, California, USA.
  • Chung W; Department of Neurology, University of California San Francisco Division of Hospital Medicine, San Francisco, California, USA.
  • Weaver KN; Department of Medical Genetics, University of Alberta Hospital, Edmonton, Alberta, Canada.
  • Owens JW; ARUP Laboratories, Salt Lake City, Utah, USA.
  • Husami A; Department of Pathology, University of Utah, Salt Lake City, Utah, USA.
  • Chaudhari BP; Division of Medical Genetics, Department of Pediatrics, University of Utah, Salt Lake City, Utah, USA.
  • Stone BS; Institute of Human Genetics, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munchen, Germany.
  • Burns K; Fachbereich Neuromuskuläre Erkrankungen und klinische Neurophysiologie, Dr. v. Hauner Children's Hospital, Ludwig-Maximilians-Universität, Munich, Germany.
  • Li R; Division of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
  • de Lange IM; Departments of Pediatrics and Medicine, Columbia University, New York City, New York, USA.
  • Biehler M; Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Ginglinger E; Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Gérard B; Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Stottmann RW; Divisions of Neonatology, Genetics and Genomic Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.
  • Trimouille A; Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, USA.
J Med Genet ; 60(10): 999-1005, 2023 10.
Article em En | MEDLINE | ID: mdl-37185208
ABSTRACT

PURPOSE:

ARF1 was previously implicated in periventricular nodular heterotopia (PVNH) in only five individuals and systematic clinical characterisation was not available. The aim of this study is to provide a comprehensive description of the phenotypic and genotypic spectrum of ARF1-related neurodevelopmental disorder.

METHODS:

We collected detailed phenotypes of an international cohort of individuals (n=17) with ARF1 variants assembled through the GeneMatcher platform. Missense variants were structurally modelled, and the impact of several were functionally validated.

RESULTS:

De novo variants (10 missense, 1 frameshift, 1 splice altering resulting in 9 residues insertion) in ARF1 were identified among 17 unrelated individuals. Detailed phenotypes included intellectual disability (ID), microcephaly, seizures and PVNH. No specific facial characteristics were consistent across all cases, however microretrognathia was common. Various hearing and visual defects were recurrent, and interestingly, some inflammatory features were reported. MRI of the brain frequently showed abnormalities consistent with a neuronal migration disorder.

CONCLUSION:

We confirm the role of ARF1 in an autosomal dominant syndrome with a phenotypic spectrum including severe ID, microcephaly, seizures and PVNH due to impaired neuronal migration.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Heterotopia Nodular Periventricular / Deficiência Intelectual / Microcefalia Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Heterotopia Nodular Periventricular / Deficiência Intelectual / Microcefalia Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article